Company Filing History:
6 out of 15 
3 out of 33 
Years Active: 2010-2015
Title: Yongxin Ren: Innovator in Quinazoline Compounds
Introduction
Yongxin Ren is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quinazoline compounds. With a total of nine patents to his name, Ren's research focuses on developing compounds that can effectively inhibit the overexpression and activity of the epidermal growth factor receptor (EGFR).
Latest Patents
Among his latest patents, Ren has developed certain quinazoline compounds, which include compositions and methods of use. These compounds are designed to target and inhibit EGFR, which plays a crucial role in various cancers. Additionally, he has patented a compound of Formula A, along with its pharmaceutically acceptable salts and crystalline forms. His work also encompasses methods for the preparation of these compounds and their pharmaceutical compositions.
Career Highlights
Yongxin Ren has worked with notable companies in the pharmaceutical industry, including Hutchison Medipharma Enterprises Limited and Hutchison Medipharma Limited. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Ren has collaborated with esteemed colleagues in his field, including Wei-Guo Su and Weihan Zhang. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in pharmaceutical research.
Conclusion
Yongxin Ren's contributions to the field of pharmaceutical chemistry, particularly through his work on quinazoline compounds, highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in cancer treatment.